These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6379717)

  • 21. Diagnosis and treatment of psychiatric and behavioural disorders in mentally retarded individuals: the state of the art.
    Dosen A
    J Intellect Disabil Res; 1993 Oct; 37 Suppl 1():1-7. PubMed ID: 8274825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.
    Aman MG; Sarphare G; Burrow WH
    Am J Ment Retard; 1995 Mar; 99(5):500-9. PubMed ID: 7779345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavior problems in adults with mental retardation. Psychopharmaceuticals are used too often--pedagogical efforts would be better].
    Näslund I
    Lakartidningen; 2007 Apr 4-17; 104(14-15):1132-5. PubMed ID: 17472101
    [No Abstract]   [Full Text] [Related]  

  • 25. Implementation of a psychotropic drug review service in a mental retardation facility.
    Marcoux AW
    Hosp Pharm; 1985 Nov; 20(11):827-31. PubMed ID: 10274172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Number of nonassessable items and Cooperation level of the retarded during systematic dyskinesia examinations.
    Kalachnik JE; Kidd-Nielsen P; Harder SR
    Psychopharmacol Bull; 1983; 19(1):16-9. PubMed ID: 6828620
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychotropic medication in adults with mental retardation: prevalence, and prescription practices.
    Holden B; Gitlesen JP
    Res Dev Disabil; 2004; 25(6):509-21. PubMed ID: 15541629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot study on the use of psychotropic medication in persons with mental retardation.
    Radouco-Thomas M; Bolduc M; Brisson A; Brassard P; Fortier L; Thivierge J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):879-83. PubMed ID: 15363610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trimonam and mental retardation.
    Huston I; Swett C; Cole JO
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):70-2. PubMed ID: 401715
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychoactive drugs used with adults and elderly adults who have mental retardation.
    Pary R
    Am J Ment Retard; 1993 Jul; 98(1):121-7. PubMed ID: 8103995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: an overview.
    Matson JL; Neal D
    Res Dev Disabil; 2009; 30(3):572-86. PubMed ID: 18845418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Learning disabilities. Challenging service.
    Matthews DR
    Nurs Times; 1995 Jun 7-13; 91(23):59-61. PubMed ID: 7603881
    [No Abstract]   [Full Text] [Related]  

  • 33. Psychoactive drug use in an institution for intellectually handicapped persons.
    Curtis JM
    Med J Aust; 1992 Jan; 156(1):69. PubMed ID: 1637368
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of a system to monitor effects of psychotropic medication in an applied setting.
    Kalachnik JE; Miller RF; Jamison AG; Harder SR
    Psychopharmacol Bull; 1983; 19(1):12-5. PubMed ID: 6828619
    [No Abstract]   [Full Text] [Related]  

  • 36. City-wide survey of drug patterns among non-institutionalised retarded persons.
    Aman M
    N Z Med J; 1985 Jun; 98(781):509. PubMed ID: 3859783
    [No Abstract]   [Full Text] [Related]  

  • 37. Behavior-disordered and aggressive children: new advances in pharmacotherapy.
    Campbell M; Anderson LT; Green WH
    J Dev Behav Pediatr; 1983 Dec; 4(4):265-71. PubMed ID: 6582068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of risperidone among individuals with mental retardation: clinically supported or not?
    Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
    Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practitioner review: Psychopharmacology in children and adolescents with mental retardation.
    Handen BL; Gilchrist R
    J Child Psychol Psychiatry; 2006 Sep; 47(9):871-82. PubMed ID: 16930381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The psychiatrist in an institution for the social care of mentally handicapped children].
    Drvota S; Müllerová D
    Cesk Pediatr; 1981 Apr; 36(4):203-5. PubMed ID: 7285207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.